CB-1 receptor modulator formulations
OwnerCraig McKelvey, Sarah Geers +4inventors
InventorsCraig McKelvey, Sarah Geers, Justin Moser, Bhagwant Rege, Dina Zhang, Sutthilug Sotthivirat
Life of this patent
Estimating the term…
Abstract
Described herein are solid, stable pharmaceutical formulations of cannabinoid receptor inverse agonists, such as taranabant, and processes of making such formulations. Additionally, described herein are solid stable pharmaceutical formulations of cannabinoid inverse agonists, such as taranabant, and an additional therapeutic agent, as well as processes for making such pharmaceutical formulations.
Claims20
A pharmaceutical formulation comprising a solid dispersion comprising a cannabinoid receptor inverse agonist having formula I:
- and a concentration-enhancing polymer.
A pharmaceutical dosage from comprising a solid dispersion comprising a cannabinoid receptor inverse agonist having formula I:
- and hydroxypropyl methyl cellulose acetate succinate;
- and wherein the pharmaceutical dosage form further comprises sitagliptin phosphate.
A method of treating obesity comprising administering to a patient a pharmaceutical formulation comprising a solid dispersion comprising a cannabinoid receptor inverse agonist having formula I:
- and a concentration enhancing polymer.
Dependencies are inferred from the claim text.